Page 1984

Suzet Leyva Gonzalez’s New Book El Libro De Marcos Y Los Mundos Perdidos, A Mystical Novel Of A Journey Through The Perspective Of A Lost Deity And A Doubting Child

0
Suzet-Leyva-Gonzalez

LANSING, Michigan, July 10, 2020 /PRNewswire-HISPANIC PR WIRE/ — The book El Libro de Marcos y los Mundos Perdidos was created by Suzet Leyva Gonzalez. Suzet is an author from Cuba who graduated in Russian and Spanish language and literature. She currently lives in Michigan.

Gonzalez said this about her book: “This book is a deep journey into the mind of a forgotten god, an escape to the world of dreams within the mind of a child who does not want to accept his reality. Sometimes the creation beats the creator.”

Published by Page Publishing, Suzet Leyva Gonzalez’s new book El Libro de Marcos y los Mundos Perdidos will embark the readers on a thought-provoking path of philosophies and circumstances that prove how mundaneness supersedes divinity in certain dribbles of time.

Consumerscan purchase El Libro de Marcos y los Mundos Perdidos in any bookstore, or online at Apple iTunes, Amazon.com, Google Play, or Barnes and Noble.

For additional information or inquiries, you can contact Page Publishing, through the following number: 866-315-2708.

About Page Publishing:
Page Publishing is a traditional full-service publishing house that handles all of the intricacies involved in publishing its authors’ books, including distribution in the world’s largest retail outlets and royalty generation. Page Publishing knows that authors need to be free to create, not bogged down with complicated business issues like eBook conversion, establishing wholesale accounts, insurance, shipping, taxes, and the like. Its roster of authors can leave behind these tedious, complex, and time-consuming issues and focus on their passion: writing and creating. Learn more at www.pagepublishing.com.

Photo – https://mma.prnewswire.com/media/1212852/Suzet_Leyva_Gonzalez.jpg

SOURCE Page Publishing

Mariah Matsushima’s New Book Mi Definición De Miedo, An Alluring Read That Mirrors One’s Deepest Fears And Ushers In Triumph Over Dread

0
Mariah-Matsushima

NEW YORK, July 10, 2020 /PRNewswire-HISPANIC PR WIRE/ — The book Mi Definición de Miedo was created by Mariah Matsushima. Mariah is an author and chef who came from Mexico, where she studied decorative arts, tailoring and fashion design, social work, and psychology.

Mariah said this about her book: “Mi Definición de Miedo is a small mirror where at least one of your fears will be reflected. You can open up and find yourself.

Don’t let your fears run your life, give yourself a chance to be the star of your story. Even with all the things you have to face there is always more than one hope, do not keep in the drawer everything you could achieve if you let go of your fears.

In your life you rule and only you decide each step you take. Ask the Creator for his blessing, to decide wisely, be sure that you will act correctly.”

Published by Page Publishing, Mariah Matsushima’s new book Mi Definición de Miedo will guide readers in their journey to discerning their hidden anxieties that ultimately paves a path for courage and wisdom to reign and vanquish their iniquities.

Consumers who wish to be liberated from terror and understand the true meaning of faith in times of alarm can purchase Mi Definición de Miedo in any bookstore, or online at Apple iTunes, Amazon.com, Google Play, or Barnes and Noble.

For additional information or inquiries, you can contact Page Publishing, through the following number: 866-315-2708.

About Page Publishing:

Page Publishing is a traditional full-service publishing house that handles all of the intricacies involved in publishing its authors’ books, including distribution in the world’s largest retail outlets and royalty generation. Page Publishing knows that authors need to be free to create, not bogged down with complicated business issues like eBook conversion, establishing wholesale accounts, insurance, shipping, taxes, and the like. Its roster of authors can leave behind these tedious, complex, and time-consuming issues and focus on their passion: writing and creating. Learn more at www.pagepublishing.com.

Photo – https://mma.prnewswire.com/media/1212722/Mariah_Matsushima.jpg

SOURCE Page Publishing

Mariah Matsushima’s New Book Mi Definición De Miedo, An Alluring Read That Mirrors One’s Deepest Fears And Ushers In Triumph Over Dread

0
Mariah-Matsushima

NEW YORK, July 10, 2020 /PRNewswire-HISPANIC PR WIRE/ — The book Mi Definición de Miedo was created by Mariah Matsushima. Mariah is an author and chef who came from Mexico, where she studied decorative arts, tailoring and fashion design, social work, and psychology.

Mariah said this about her book: “Mi Definición de Miedo is a small mirror where at least one of your fears will be reflected. You can open up and find yourself.

Don’t let your fears run your life, give yourself a chance to be the star of your story. Even with all the things you have to face there is always more than one hope, do not keep in the drawer everything you could achieve if you let go of your fears.

In your life you rule and only you decide each step you take. Ask the Creator for his blessing, to decide wisely, be sure that you will act correctly.”

Published by Page Publishing, Mariah Matsushima’s new book Mi Definición de Miedo will guide readers in their journey to discerning their hidden anxieties that ultimately paves a path for courage and wisdom to reign and vanquish their iniquities.

Consumers who wish to be liberated from terror and understand the true meaning of faith in times of alarm can purchase Mi Definición de Miedo in any bookstore, or online at Apple iTunes, Amazon.com, Google Play, or Barnes and Noble.

For additional information or inquiries, you can contact Page Publishing, through the following number: 866-315-2708.

About Page Publishing:

Page Publishing is a traditional full-service publishing house that handles all of the intricacies involved in publishing its authors’ books, including distribution in the world’s largest retail outlets and royalty generation. Page Publishing knows that authors need to be free to create, not bogged down with complicated business issues like eBook conversion, establishing wholesale accounts, insurance, shipping, taxes, and the like. Its roster of authors can leave behind these tedious, complex, and time-consuming issues and focus on their passion: writing and creating. Learn more at www.pagepublishing.com.

Photo – https://mma.prnewswire.com/media/1212722/Mariah_Matsushima.jpg

SOURCE Page Publishing

(Español) El Honda Civic Type R de Edición Limitada de 2021 fija un récord en el Circuito de Suzuka

0
The 2021 Honda Civic Type R Limited Edition stormed to a new front-wheel drive track record at Suzuka Circuit, Honda’s Formula 1 racetrack in Japan, with a time of 2 minutes 23.993 seconds. Originally built as a test facility for Honda, the 3.6-mile Suzuka track’s figure-8 configuration today is known worldwide as a highlight of the Formula 1 season as a driver and fan favorite.

Sorry, this entry is only available in Español.

2021 Honda Civic Type R Limited Edition Sets Suzuka Track Record

0
The 2021 Honda Civic Type R Limited Edition stormed to a new front-wheel drive track record at Suzuka Circuit, Honda’s Formula 1 racetrack in Japan, with a time of 2 minutes 23.993 seconds. Originally built as a test facility for Honda, the 3.6-mile Suzuka track’s figure-8 configuration today is known worldwide as a highlight of the Formula 1 season as a driver and fan favorite.

TORRANCE, Calif., July 9, 2020 /PRNewswire-HISPANIC PR WIRE/ — The 2021 Honda Civic Type R Limited Edition stormed to a new front-wheel drive track record at Suzuka Circuit, Honda’s Formula 1 racetrack in Japan, with a time of 2 minutes 23.993 seconds. Originally built as a test facility for Honda, the 3.6-mile Suzuka track’s figure-8 configuration today is known worldwide as a highlight of the Formula 1 season as a driver and fan favorite.

The 2021 Honda Civic Type R Limited Edition stormed to a new front-wheel drive track record at Suzuka Circuit, Honda’s Formula 1 racetrack in Japan, with a time of 2 minutes 23.993 seconds. Originally built as a test facility for Honda, the 3.6-mile Suzuka track’s figure-8 configuration today is known worldwide as a highlight of the Formula 1 season as a driver and fan favorite.

Piloted by Super GT Series racer Takuya Izawa, the Type R Limited Edition achieved its record-breaking lap during final performance evaluations in February using a development car built to final European production specifications, with no modifications or performance enhancements. Video capturing the record breaking lap through in-car footage is available here, with a separate video of the development crew working on the Type R at the track here.

“The Type R Limited Edition reflects Honda’s dedication to refining the essence and driving pleasure of Type R as a sports car and exceeding the expectations of our customers,” said Civic Type R Project Leader Hideki Kakinuma. “The engineering team and I embraced a racing spirit that has been passed down for generations, and it’s this strong passion that’s driving the evolution of the Civic Type R towards becoming the ideal sports car. Now the “advanced” Type R that I envisioned at the beginning of this development is a reality and I am overwhelmed by the result and how our efforts have been rewarded.”

The 2021 Type R Limited Edition for the U.S. market is the ultimate street-legal, track-focused variant of Honda’s legendary Civic Type R, with significant measures taken to reduce weight and improve handling performance. Just 600 will be available when it launches in the U.S. later this year, exclusively painted in new Phoenix Yellow Pearl with contrasting gloss black accents on the roof and mirrors, and a dark chrome Civic badge. Inside, each Type R Limited Edition will feature an individually numbered serial plate denoting the vehicle’s original country of sale. The U.S.-spec Type R Limited Edition differs from the European version by retaining air conditioning, Honda Sensing®, and the Display Audio system.

2021 Civic Type R Limited Edition mechanical upgrades from the standard Type R for the U.S. market include: Lightweight, forged aluminum wheels from acclaimed manufacturer BBS (18 lbs. unsprung weight reduction); Michelin Pilot Sport Cup 2 tires for improved traction and handling grip; dampers optimized for the new wheel/tire package; recalibrated steering for finer control and feedback; and further weight reduction of 28.2 lbs. through measures such as strategic reduction of sound-deadening materials.

In addition to its unique touches, the Type R Limited Edition shares most of the updates that debuted on the 2020 Civic Type R, including freshened front and rear exterior styling, a larger grille and revised radiator design for improved engine cooling, an Alcantara™-wrapped steering wheel, and a new shifter with a restyled knob, plus the Honda Sensing® suite of safety and driver-assistive technologies.

Under the hood, the Type R Limited Edition draws power from the same race-bred 2.0-liter VTEC® Turbo engine, putting out a peak 306-horsepower (SAE net) and 295 lb.-ft. of torque (SAE net), with power delivered to the front wheels through a close-ratio 6-speed manual transmission and limited-slip differential.

The substantial power and torque is effectively managed by Type R’s dual axis strut front suspension system which virtually eliminates torque steer while allowing geometry optimized for maximum cornering performance.

About Honda
Honda offers a full line of reliable, fuel-efficient and fun-to-drive vehicles with advanced safety technologies sold through over 1,000 independent U.S. Honda dealers. The Honda lineup includes the Fit, Civic and Accord passenger cars, along with the HR-V, CR-V, Passport and Pilot sport utility vehicles, the Ridgeline pickup and the Odyssey minivan. Honda’s electrified vehicle lineup includes the Insight hybrid-electric sedan, Accord Hybrid, CR-V Hybrid, and the Clarity series. 

Honda has been producing automobiles in America for more than 35 years and currently operates 19 major manufacturing facilities in North America. In 2019, more than 90 percent of all Honda brand vehicles sold in the U.S. were made in North America, using domestic and globally sourced parts.

For More Information
Additional media information including detailed pricing features and high-resolution photography of all 2020 Honda models is available at hondanews.com. Consumer information is available at automobiles.honda.com.

Honda Logo. (PRNewsFoto/American Honda Motor Co., Inc. )

Photo – https://mma.prnewswire.com/media/1212424/Honda_Civic_Type_R_Limited_Edition_at_Suzuka_Circuit.jpg
Logo – https://mma.prnewswire.com/media/451598/Honda_Logo.jpg

SOURCE American Honda Motor Co., Inc.

Addiction Medicine Fellowship Brings More Substance Abuse Treatment to Community Settings

0
Montefiore_Logo

BRONX, New York, July 9, 2020 /PRNewswire-HISPANIC PR WIRE/ — Every six hours, a person dies from a drug overdose in New York City, with more deaths in the Bronx than any other borough. COVID-19 has made the overdose epidemic even more dangerous because many people feel isolated and uncomfortable going to hospitals to get care.

To ensure people get the substance use disorder treatment they need, Montefiore Health System and Albert Einstein College of Medicine have been awarded a $4 million grant from the United States Department of Health and Human Services (HHS) to train physicians in addiction medicine and strengthen relationships with community partners. The Montefiore-Einstein Addiction Medicine Fellowship, started in 2019, continues to expand our commitment to advancing substance use disorder treatment in the Bronx community.

“We are proud of our long-established programs, but now more than ever, we need to increase the number of physicians equipped to treat those with substance use disorders and our presence in community-based settings,” said Shadi Nahvi, M.D., M.S., director, Addiction Medicine Fellowship program at Montefiore and Einstein, and associate professor of medicine and of psychiatry and behavioral sciences at Einstein.

The five-year HHS grant will fund an Accreditation Council for Graduate Medical Education (ACGME)-addiction medicine fellowship program to train new doctors on a team approach which includes nurses, counselors, social workers, nursing homes, pharmacists and community-based organizations so treatment can start as early as possible, regardless of where people are seeking help.

Training will occur at clinical settings like the Montefiore Einstein Division of Substance Abuse and the Montefiore Buprenorphine Treatment Network, which for decades been a leader in using medication to support treatment of opioid and alcohol abuse disorders and providing primary care.

The fellows will then complete their training at organizations like New York Harm Reduction Educators, which provides safe syringes and engages people who use drugs. Additionally, the fellows will partner with community groups, including BronxWorks, the Harm Reduction Coalition, the Osborne Association, the Drug Policy Alliance, and the NYC Department of Health and Mental Hygiene to improve care.

By having clinicians in community locations that provide critical services like food and shelter, Montefiore doctors can prescribe buprenorphine to prevent withdrawal and block the pleasurable effects of using opioids and be primary care doctors when needed, treating conditions such as HIV and Hepatitis C.

“Our hope is that by partnering closely with our community, our addiction medicine fellows can become change agents – and rethink how to deliver the best care possible during this pandemic and well into the future,” said Dr. Nahvi.

About Montefiore Health System

Montefiore Health System is one of New York’s premier academic health systems and is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester and the Hudson Valley. It is comprised of 11 hospitals, including the Children’s Hospital at Montefiore, Burke Rehabilitation Hospital and more than 200 outpatient ambulatory care sites. The advanced clinical and translational research at its medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information please visit www.montefiore.org. Follow us on Twitter and view us on Facebook and YouTube.

About Albert Einstein College of Medicine

Albert Einstein College of Medicine is one of the nation’s premier centers for research, medical education and clinical investigation. During the 2019-20 academic year, Einstein is home to 724 M.D. students, 158 Ph.D. students, 106 students in the combined M.D./Ph.D. program, and 265 postdoctoral research fellows. The College of Medicine has more than 1,800 full-time faculty members located on the main campus and at its clinical affiliates. In 2019, Einstein received more than $178 million in awards from the National Institutes of Health (NIH). This includes the funding of major research centers at Einstein in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States through Montefiore and an affiliation network involving hospitals and medical centers in the Bronx, Brooklyn and on Long Island. For more information, please visit www.einstein.yu.edu, read our blog, follow us on Twitter, like us on Facebook, and view us on YouTube.

Logo – https://mma.prnewswire.com/media/675671/Montefiore_Logo.jpg

SOURCE Montefiore Health System

Addiction Medicine Fellowship Brings More Substance Abuse Treatment to Community Settings

0
Montefiore_Logo

BRONX, New York, July 9, 2020 /PRNewswire-HISPANIC PR WIRE/ — Every six hours, a person dies from a drug overdose in New York City, with more deaths in the Bronx than any other borough. COVID-19 has made the overdose epidemic even more dangerous because many people feel isolated and uncomfortable going to hospitals to get care.

To ensure people get the substance use disorder treatment they need, Montefiore Health System and Albert Einstein College of Medicine have been awarded a $4 million grant from the United States Department of Health and Human Services (HHS) to train physicians in addiction medicine and strengthen relationships with community partners. The Montefiore-Einstein Addiction Medicine Fellowship, started in 2019, continues to expand our commitment to advancing substance use disorder treatment in the Bronx community.

“We are proud of our long-established programs, but now more than ever, we need to increase the number of physicians equipped to treat those with substance use disorders and our presence in community-based settings,” said Shadi Nahvi, M.D., M.S., director, Addiction Medicine Fellowship program at Montefiore and Einstein, and associate professor of medicine and of psychiatry and behavioral sciences at Einstein.

The five-year HHS grant will fund an Accreditation Council for Graduate Medical Education (ACGME)-addiction medicine fellowship program to train new doctors on a team approach which includes nurses, counselors, social workers, nursing homes, pharmacists and community-based organizations so treatment can start as early as possible, regardless of where people are seeking help.

Training will occur at clinical settings like the Montefiore Einstein Division of Substance Abuse and the Montefiore Buprenorphine Treatment Network, which for decades been a leader in using medication to support treatment of opioid and alcohol abuse disorders and providing primary care.

The fellows will then complete their training at organizations like New York Harm Reduction Educators, which provides safe syringes and engages people who use drugs. Additionally, the fellows will partner with community groups, including BronxWorks, the Harm Reduction Coalition, the Osborne Association, the Drug Policy Alliance, and the NYC Department of Health and Mental Hygiene to improve care.

By having clinicians in community locations that provide critical services like food and shelter, Montefiore doctors can prescribe buprenorphine to prevent withdrawal and block the pleasurable effects of using opioids and be primary care doctors when needed, treating conditions such as HIV and Hepatitis C.

“Our hope is that by partnering closely with our community, our addiction medicine fellows can become change agents – and rethink how to deliver the best care possible during this pandemic and well into the future,” said Dr. Nahvi.

About Montefiore Health System

Montefiore Health System is one of New York’s premier academic health systems and is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester and the Hudson Valley. It is comprised of 11 hospitals, including the Children’s Hospital at Montefiore, Burke Rehabilitation Hospital and more than 200 outpatient ambulatory care sites. The advanced clinical and translational research at its medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information please visit www.montefiore.org. Follow us on Twitter and view us on Facebook and YouTube.

About Albert Einstein College of Medicine

Albert Einstein College of Medicine is one of the nation’s premier centers for research, medical education and clinical investigation. During the 2019-20 academic year, Einstein is home to 724 M.D. students, 158 Ph.D. students, 106 students in the combined M.D./Ph.D. program, and 265 postdoctoral research fellows. The College of Medicine has more than 1,800 full-time faculty members located on the main campus and at its clinical affiliates. In 2019, Einstein received more than $178 million in awards from the National Institutes of Health (NIH). This includes the funding of major research centers at Einstein in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States through Montefiore and an affiliation network involving hospitals and medical centers in the Bronx, Brooklyn and on Long Island. For more information, please visit www.einstein.yu.edu, read our blog, follow us on Twitter, like us on Facebook, and view us on YouTube.

Logo – https://mma.prnewswire.com/media/675671/Montefiore_Logo.jpg

SOURCE Montefiore Health System

Addiction Medicine Fellowship Brings More Substance Abuse Treatment to Community Settings

0
Montefiore_Logo

BRONX, New York, July 9, 2020 /PRNewswire-HISPANIC PR WIRE/ — Every six hours, a person dies from a drug overdose in New York City, with more deaths in the Bronx than any other borough. COVID-19 has made the overdose epidemic even more dangerous because many people feel isolated and uncomfortable going to hospitals to get care.

To ensure people get the substance use disorder treatment they need, Montefiore Health System and Albert Einstein College of Medicine have been awarded a $4 million grant from the United States Department of Health and Human Services (HHS) to train physicians in addiction medicine and strengthen relationships with community partners. The Montefiore-Einstein Addiction Medicine Fellowship, started in 2019, continues to expand our commitment to advancing substance use disorder treatment in the Bronx community.

“We are proud of our long-established programs, but now more than ever, we need to increase the number of physicians equipped to treat those with substance use disorders and our presence in community-based settings,” said Shadi Nahvi, M.D., M.S., director, Addiction Medicine Fellowship program at Montefiore and Einstein, and associate professor of medicine and of psychiatry and behavioral sciences at Einstein.

The five-year HHS grant will fund an Accreditation Council for Graduate Medical Education (ACGME)-addiction medicine fellowship program to train new doctors on a team approach which includes nurses, counselors, social workers, nursing homes, pharmacists and community-based organizations so treatment can start as early as possible, regardless of where people are seeking help.

Training will occur at clinical settings like the Montefiore Einstein Division of Substance Abuse and the Montefiore Buprenorphine Treatment Network, which for decades been a leader in using medication to support treatment of opioid and alcohol abuse disorders and providing primary care.

The fellows will then complete their training at organizations like New York Harm Reduction Educators, which provides safe syringes and engages people who use drugs. Additionally, the fellows will partner with community groups, including BronxWorks, the Harm Reduction Coalition, the Osborne Association, the Drug Policy Alliance, and the NYC Department of Health and Mental Hygiene to improve care.

By having clinicians in community locations that provide critical services like food and shelter, Montefiore doctors can prescribe buprenorphine to prevent withdrawal and block the pleasurable effects of using opioids and be primary care doctors when needed, treating conditions such as HIV and Hepatitis C.

“Our hope is that by partnering closely with our community, our addiction medicine fellows can become change agents – and rethink how to deliver the best care possible during this pandemic and well into the future,” said Dr. Nahvi.

About Montefiore Health System

Montefiore Health System is one of New York’s premier academic health systems and is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester and the Hudson Valley. It is comprised of 11 hospitals, including the Children’s Hospital at Montefiore, Burke Rehabilitation Hospital and more than 200 outpatient ambulatory care sites. The advanced clinical and translational research at its medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information please visit www.montefiore.org. Follow us on Twitter and view us on Facebook and YouTube.

About Albert Einstein College of Medicine

Albert Einstein College of Medicine is one of the nation’s premier centers for research, medical education and clinical investigation. During the 2019-20 academic year, Einstein is home to 724 M.D. students, 158 Ph.D. students, 106 students in the combined M.D./Ph.D. program, and 265 postdoctoral research fellows. The College of Medicine has more than 1,800 full-time faculty members located on the main campus and at its clinical affiliates. In 2019, Einstein received more than $178 million in awards from the National Institutes of Health (NIH). This includes the funding of major research centers at Einstein in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States through Montefiore and an affiliation network involving hospitals and medical centers in the Bronx, Brooklyn and on Long Island. For more information, please visit www.einstein.yu.edu, read our blog, follow us on Twitter, like us on Facebook, and view us on YouTube.

Logo – https://mma.prnewswire.com/media/675671/Montefiore_Logo.jpg

SOURCE Montefiore Health System